New agreement formed to tackle multidrug-resistant and extensively drug-resistant TB
A brand new consensus statement has been formed that will help to tackle the increasing threat of multidrug-resistant tuberculosis (TB) and also extensively drug-resistant tuberculosis (TB). As per a new study published in the European Respiratory Journal¸ there are new statements proposed that will help the physicians to deal with the patients sufferings with multidrug- and extensively drug-resistant TB. These practitioners have finally led to consensus on the major areas of patient management where scientific issues are inconclusive.
The principle author, Professor Christoph Lange, Head of the Respiratory Infections Assembly at the European Respiratory Society, explains, “These consensus statements provide very valuable support for physicians treating patients with these deadly conditions in all parts of Europe. The current management of patients with multidrug- and extensively drug-resistant TB is complex, very costly for healthcare systems and burdensome for those who are affected.”